在今天的发布仪式上，今海医疗与美敦力康辉的领导共同出席了活动。双方表示，此次合作是中国医疗 科技力量从"跟随者"迈向"共创者"的有力证明。今海医疗以自身在脊柱内镜领域的深厚积淀，补全并增 强了美敦力康辉的产品矩阵与临床服务能力；同时，也借助其全球平台，验证了中国原创技术的全球适 用性。这种"双向赋能"正推动全球脊柱微创领域突破资源与技术边界，迈向"系统服务"的更高维度。 精彩继续，共赴数智骨科新程 2025年11月13日，在第十七届COA学术大会召开之际，今海医疗科技股份有限公司（02225.HK，以下 简称"今海医疗"）与美敦力康辉在国家会展中心（天津）联合举办发布会，正式发布双方共同打造 的"导航下脊柱内镜微创技术"。此次发布是美敦力康辉展台系列"至新·思享时刻"主题活动的核心环 节，标志着双方在AiBLE™数智创新生态下的合作取得里程碑式进展，为脊柱微创手术带来了更精准、 更安全、更智能的系统性解决方案。 技术落地，引领脊柱微创进入"导航内镜"融合新阶段 本次联合发布的技术，成功将今海医疗顶尖的脊柱内镜系统与美敦力康辉本土研发的"擎航™ EngineNav™ 脊柱外科手术导航系统"深度融合。该方案实现了 ...

2025年11月13日，在第十七届COA学术大会现场，今海医疗（02225.HK）与美敦力康辉于美敦力展台 联合发布"导航下脊柱内镜微创技术"，标志着双方在AiBLE™数智创新生态下的合作迎来里程碑成果。 本次发布的技术深度融合了今海医疗的脊柱内镜系统与美敦力康辉的"擎航™"手术导航系统，旨在推动 脊柱手术迈向"可视化、精准化、微创化"新阶段。作为"至新·思享时刻"系列活动的核心环节，双方还 将于14日带来多场专题技术分享，展现从"单点创新"到"系统服务"的战略升级。 ...

Core Viewpoint - The eighth China International Import Expo (CIIE) showcases Medtronic's commitment to local innovation and global collaboration in high-end medical equipment, highlighting the launch of innovative technologies in minimally invasive surgery [1][3][10]. Group 1: Innovation and Technology - Medtronic's AiBLE digital innovation ecosystem, first introduced at the sixth CIIE in 2023, aims to transition orthopedic and neurosurgery from "single-point innovation" to "system collaboration" [4]. - The company presented several star products from the AiBLE ecosystem, including the Mazor XC spinal surgery robot and the NIM-Eclipse intraoperative neuro-monitoring system, which have successfully transitioned from exhibition to clinical application [4][15]. - Medtronic, in collaboration with Jin Hai Medical and Jia Liang Medical, launched two innovative technologies: "navigation-assisted spinal endoscopic minimally invasive technology" and "robot-guided laser ablation minimally invasive technology" [1][10]. Group 2: Local Collaboration and Market Expansion - Medtronic emphasizes deepening local innovation partnerships to explore new technologies and trends in orthopedic and neurosurgery, responding to the growing demand for minimally invasive procedures [10][11]. - The company has established a comprehensive global capability covering research, manufacturing, registration, and sales, with products now available in 65 countries and regions [12]. - The NIM-Eclipse system has recently entered the Japanese market, marking a significant milestone in Medtronic's global expansion efforts [12][15]. Group 3: Future Outlook - Medtronic aims to continue leveraging the AiBLE digital innovation ecosystem to foster open collaboration and sustainable development in medical innovation, ensuring that Chinese innovations benefit global patients [15].

Group 1: Health Education and Management - The China International Import Expo (CIIE) serves as a platform for disseminating health science and advanced treatment techniques, focusing on obesity management and chronic disease care [1][2] - A new encyclopedia on weight management was launched, emphasizing the need for scientific approaches to obesity under medical guidance, with contributions from 180 experts [1] - The collaboration between WeDoctor and Abbott aims to establish a comprehensive digital management system for diabetes, shifting from reactive treatment to proactive health management [2] Group 2: Cancer Treatment Innovations - Lung cancer precision treatment is a key focus, with discussions on the importance of exploring combination therapies for rare target mutations [2][3] - Bayer is committed to enhancing drug accessibility and developing innovative treatments in collaboration with clinical experts [3] Group 3: Chronic Kidney Disease and Cardiovascular Management - The concept of Cardiovascular-Kidney-Metabolic (CKM) syndrome highlights the interconnectedness of diseases like obesity, diabetes, and chronic kidney disease, necessitating a holistic management approach [3][4] - Experts advocate for early detection and intervention in CKM-related diseases, emphasizing the role of endocrinology in managing these conditions [4] - The China Population Welfare Foundation is working to integrate resources for CKM management, promoting a collaborative model that involves medical, public welfare, and social participation [4] Group 4: Technological Advancements in Medical Procedures - The trend towards intelligent and minimally invasive spinal surgery is being supported by new technologies introduced at the CIIE, including navigation-assisted endoscopic techniques [4]

Core Insights - Medtronic's AiBLE ecosystem showcases its commitment to local innovation and global sharing in high-end medical equipment, emphasizing the importance of collaborative advancements in the orthopedic and neurosurgery fields [1][5][6] Group 1: AiBLE Ecosystem and Innovations - The AiBLE ecosystem integrates surgical robots, navigation systems, intraoperative imaging, and power devices, aiming to transition from "single-point innovation" to "system collaboration" [1][2] - New technologies such as "navigation-assisted spinal endoscopic minimally invasive technology" and "robot-guided laser ablation minimally invasive technology" were launched in collaboration with local partners [1][3] - The ecosystem's products, including the Mazor XC spinal surgery robot and NIM-Eclipse intraoperative neuro-monitoring system, have successfully transitioned from exhibition to clinical application [2] Group 2: Collaboration with Local Partners - Medtronic collaborates with local companies like Jin Hai Medical and Jia Liang Medical to explore new technologies and trends in orthopedic and neurosurgery [3][4] - The partnership with Jin Hai Medical focuses on integrating endoscopic technology into spinal surgeries, responding to the growing demand for minimally invasive procedures [3] - Jia Liang Medical's collaboration aims to enhance the application of the LITT system in domestic medical institutions, promoting advanced therapies for a broader patient base [4] Group 3: Global Expansion and Market Impact - Medtronic celebrates its 20th anniversary of global expansion, marking a significant milestone in its international strategy and showcasing the influence of Chinese medical innovation on the global stage [5] - The NIM-Eclipse product has received approval in Japan and is progressing in registration processes across various international markets, enhancing access to Chinese innovations for global clinical institutions [5][6] - Medtronic's products are now available in 65 countries, supported by over 600 international certifications, reflecting its comprehensive global capabilities in research, manufacturing, and sales [5]